| 10:58a | Sage Therapeutics and Biogen Announce Positive Pivotal Phase 3 Results for Zu.. | AQ |
| 09:18a | INSIDER TRENDS : Insider Purchase Continues Sage Therapeutics Positive Trend | MT |
| 09:17a | INSIDER TRENDS : Insider Purchase of Sage Therapeutics Stock Extends 90-Day Posi.. | MT |
| 09:16a | INSIDER TRENDS : Sage Therapeutics Insider Awarded Stock, Exercises Derivative S.. | MT |
| 06:12a | NORTH AMERICAN MORNING BRIEFING : Markets Slip and -3- | DJ |
| 06/16 | SAGE THERAPEUTICS : and Biogen Announce Positive Pivotal Phase 3 Results for Zu.. | AQ |
| 06/16 | SAGE THERAPEUTICS : Cowen Adjusts Sage Therapeutics' Price Target to $105 from .. | MT |
| 06/16 | SAGE THERAPEUTICS : Guggenheim Downgrades Sage Therapeutics to Neutral from Buy | MT |
| 06/16 | SAGE THERAPEUTICS : SVB Leerink Adjusts Sage Therapeutics' Price Target to to $.. | MT |
| 06/16 | SAGE THERAPEUTICS : Truist Securities Adjusts Sage Therapeutics' Price Target t.. | MT |
| 06/16 | SAGE THERAPEUTICS : BMO Capital Adjusts Price Target on Sage Therapeutics to $7.. | MT |
| 06/16 | SAGE THERAPEUTICS : Stifel Adjusts Price Target on Sage Therapeutics to $95 Fro.. | MT |
| 06/16 | SAGE THERAPEUTICS : William Blair Downgrades Sage Therapeutics to Market Perfor.. | MT |
| 06/16 | SAGE THERAPEUTICS : Citigroup Downgrades Sage Therapeutics to Neutral From Buy,.. | MT |
| 06/15 | Cracker Barrel, Sage Therapeutics fall; Ocugen, FedEx rise | AQ |
| 06/15 | SECTOR UPDATE : Health Care Stocks Mixed Premarket Tuesday | MT |
| 06/15 | SAGE THERAPEUTICS : to Host Conference Call | BU |
| 06/15 | SAGE THERAPEUTICS : Biogen Say Zuranolone Study Meets Primary Endpoint in Patie.. | MT |
| 06/15 | SAGE THERAPEUTICS : and Biogen Announce Positive Pivotal Phase 3 Results for Zu.. | PU |
| 06/15 | SAGE THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (form.. | AQ |
| 06/15 | SAGE THERAPEUTICS : depression drug meets late-stage study goal | RE |
| 06/15 | Sage, Biogen's Zuranolone Meets Primary Endpoint in Phase 3 Trial | DJ |
| 06/10 | SAGE THERAPEUTICS, INC. : Submission of Matters to a Vote of Security Holders (.. | AQ |
| 05/20 | SAGE THERAPEUTICS : Joins MTV Entertainment Group and More Than 1,300 Leading O.. | BU |
| 05/13 | SAGE THERAPEUTICS TO HOST SAGE SCIEN : SAGE-718 In Depth | BU |
| 05/05 | SAGE THERAPEUTICS : Oppenheimer Adjusts Sage Therapeutics PT to $100 From $102,.. | MT |
| 05/05 | SAGE THERAPEUTICS : RBC Capital Adjusts Sage Therapeutics' Price Target to $84 .. | MT |
| 05/05 | SAGE THERAPEUTICS : Wedbush Adjusts Price Target on Sage Therapeutics to $90 Fr.. | MT |
| 05/04 | SAGE THERAPEUTICS : Company on-track to initiate placebo-controlled Phase 2 tri.. | PU |
| 05/04 | SAGE THERAPEUTICS : Q1 Net Loss Narrows | MT |
| 05/04 | SAGE THERAPEUTICS : Management's Discussion and Analysis of Financial Condition.. | AQ |
| 05/04 | SAGE THERAPEUTICS, INC. : Results of Operations and Financial Condition, Financ.. | AQ |
| 05/04 | SAGE THERAPEUTICS : Announces First Quarter 2021 Financial Results and Highligh.. | BU |
| 04/28 | SAGE THERAPEUTICS : to Present at Upcoming May Investor Conferences | BU |
| 04/23 | DGAP-NEWS : BB BIOTECH AG: Le efficaci campagne di -2- | DJ |
| 04/20 | SAGE THERAPEUTICS : to Report First Quarter 2021 Financial Results on Tuesday, .. | BU |
| 04/12 | SAGE THERAPEUTICS : Biogen Drug Candidate's Phase 2 Study in Essential Tremor M.. | MT |
| 04/12 | Sage Therapeutics, Biogen Sees Positive Results for Essential Tremors Treatme.. | DJ |
| 04/12 | SAGE THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (form.. | AQ |
| 04/07 | SAGE THERAPEUTICS : Piper Sandler Starts Sage Therapeutics at Overweight with $.. | MT |
| 03/24 | SAGE THERAPEUTICS : to Present at the Stifel 3rd Annual CNS Day | BU |
| 03/18 | SAGE THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (form.. | AQ |
| 03/17 | SAGE THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K) | AQ |
| 03/17 | SAGE THERAPEUTICS : Reports Positive Data in Study of Depressive Disorder Drug .. | MT |
| 03/17 | SAGE THERAPEUTICS : Announces Continued Positive Zuranolone Data for Both 30 mg.. | BU |
| 03/16 | SAGE THERAPEUTICS : CFO to Step Down | MT |
| 03/16 | SAGE THERAPEUTICS : Announces Departure of Chief Operating Officer | BU |
| 03/02 | SAGE THERAPEUTICS : Morgan Stanley Adjusts Sage Therapeutics PT to $87 From $83.. | MT |
| 02/26 | SAGE THERAPEUTICS : Mizuho Downgrades Sage Therapeutics to Neutral from Buy, Se.. | MT |
| 02/25 | SAGE THERAPEUTICS : Oppenheimer Adjusts Sage Therapeutics PT to $102 From $90, .. | MT |
| 02/25 | SAGE THERAPEUTICS : RBC Adjusts Sage Therapeutics' Price Target to $89 From $86.. | MT |
| 02/24 | SAGE THERAPEUTICS : Swings to Profit, Posts Higher Revenue in Q4 | MT |
| 02/24 | SAGE THERAPEUTICS : Management's Discussion and Analysis of Financial Condition.. | AQ |
| 02/24 | SAGE THERAPEUTICS, INC. : Results of Operations and Financial Condition, Financ.. | AQ |
| 02/24 | SAGE THERAPEUTICS : Announces Fourth Quarter and Full Year 2020 Financial Resul.. | BU |
| 02/24 | SAGE THERAPEUTICS : Earnings Flash (SAGE) SAGE THERAPEUTICS Reports Q4 Revenue .. | MT |
| 02/11 | SAGE THERAPEUTICS : to Present at Upcoming Investor Conferences | BU |
| 02/10 | SAGE THERAPEUTICS : to Report Fourth Quarter and Full Year 2020 Financial Resul.. | BU |
| 02/02 | SAGE THERAPEUTICS : Raymond James Reinstates Sage Therapeutics at Market Perfor.. | MT |
| 01/22 | SAGE THERAPEUTICS : BMO Capital Downgrades Sage Therapeutics to Market Perform .. | MT |
| 01/22 | PRESS RELEASE : BB BIOTECH AG: Vaccines leading -2- | DJ |
| 01/19 | SAGE THERAPEUTICS : Wedbush Adjusts Price Target on Sage Therapeutics to $98 Fr.. | MT |
| 01/07 | SAGE THERAPEUTICS, INC. : Results of Operations and Financial Condition, Other .. | AQ |
| 01/07 | SAGE THERAPEUTICS : Provides 2021 Corporate Strategy Update at J.P. Morgan Heal.. | BU |
| 01/04 | SAGE THERAPEUTICS : Guggenheim Upgrades Sage Therapeutics to Buy From Neutral, .. | MT |
| 01/04 | SAGE THERAPEUTICS : RBC Downgrades Sage Therapeutics to Sector Perform From Out.. | MT |
| 2020 | SAGE THERAPEUTICS, INC. : Other Events (form 8-K) | AQ |
| 2020 | SAGE THERAPEUTICS : to Present at the 39th Annual J.P. Morgan Healthcare Confer.. | BU |
| 2020 | SAGE THERAPEUTICS : Names Barry Greene CEO | MT |
| 2020 | SAGE THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K) | AQ |
| 2020 | SAGE THERAPEUTICS : Announces the Appointment of Barry Greene as CEO | BU |
| 2020 | SAGE THERAPEUTICS : Mizuho Upgrades Sage Therapeutics to Buy From Neutral, Adju.. | MT |
| 2020 | SAGE THERAPEUTICS : to Present at BMO 2020 Growth and ESG Conference | AQ |
| 2020 | SAGE THERAPEUTICS : to Present at BMO 2020 Growth & ESG Conference | BU |
| 2020 | BIOGEN : Oppenheimer Sees Biogen as 'Strategic Fit' for Sage Therapeutics Colla.. | MT |
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
